Skip to main content
Clinical Trials/NCT01834612
NCT01834612CompletedPhase 1

Clinical Evaluation of the Zynex Blood Volume Monitor (CM1500) in Healthy Adult Volunteers During a Blood Draw

Zynex Monitoring Solutions2 sites in 1 country20 target enrollmentStarted: January 7, 2013Last updated:
Conditions

Trial Snapshot

Phase
Phase 1
Status
Completed
Sponsor
Enrollment
20
Locations
2
Primary Endpoint
Detect change in blood volume by non-invasive monitoring during whole blood draw

Study Overview

Brief Summary

To determine if a manual blood loss can be detected using the non-invasive blood monitor.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Diagnostic
Masking
None

Eligibility Criteria

Ages
18 Years to 50 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • healthy volunteer
  • between 18 to 50 years of age
  • weight between 157 to 220 lbs

Exclusion Criteria

  • unstable or untreated cardia disease
  • alcohol consumption in 24 hours prior to screening
  • tobacco use in 4 hours prior to screening
  • pregnancy
  • infection
  • Hemoglobin < 12.5 g/dL at time of procedure

Outcomes

Primary Outcomes

Detect change in blood volume by non-invasive monitoring during whole blood draw

Time Frame: 4 months

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Zynex Monitoring Solutions
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials